Dear Co-Diagnostics shareholders,
We are pleased to announce that we have recently deployed reagents for validation to the Monterey County Public Health Laboratory, a CLIA lab located in California, USA. These reagents represent the most recent iteration of our high-quality test for Tuberculosis, designed on the Co-Primers platform.
A US CLIA lab is one which conforms to Clinical Laboratory Improvement Amendments regulatory standards for clinical laboratory testing on human specimens, for health assessment and to diagnose, prevent, or treat disease. Having reagents placed in a lab of this caliber in the United States will help provide reassurance for our partners and investors of the quality of our tests, as well as validation of the sensitivity of our cutting-edge Co-Primers.
Results of these validation studies should be forthcoming and we look forward to making more exciting announcements in early 2015.